Practical Formulation-Associated Immunomodulatory Responses of Lacticaseibacillus paracasei Yb in an Ovalbumin-Induced Allergic Airway Inflammation Mouse Model
Microorganisms · 23.06.2026 · 14 (7) · 1389
DOI: 10.3390/microorganisms14071389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 23.06.2026. Verfasst von Yi-Fang Ho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Uni-President Enterprises Corporation, Tainan 710401, Taiwan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study evaluated the immunomodulatory activity of live Lacticaseibacillus paracasei Yb in vitro and compared response patterns associated with practical L. paracasei Yb formulation formats in an ovalbumin (OVA)-induced allergic airway inflammation mouse model. In vitro, live L. paracasei Yb increased TNF-α production in RAW 264.7 macrophages at 2 × 106 to 5 × 107 CFU/mL, increased IL-1β only at 5 × 107 CFU/mL, and increased IL-10 at 1 × 107 and 5 × 107 CFU/mL. In splenocytes, L. paracasei Yb increased TNF-α, IFN-γ, and IL-10 compared with untreated controls, although these responses did not show a simple concentration-dependent pattern. In vivo, BALB/c mice received fresh L. paracasei Yb yogurt (YG), freeze-dried yogurt (YG-FD), or bacterial powder (BP) for 53 days. Compared with the OVA-sensitized Negative control group, YG and BP did not significantly reduce serum total IgE or OVA-specific IgE, and airway responsiveness and BALF eosinophils showed limited or non-significant changes. In contrast, YG and BP significantly reduced lung inflammation scores (Negative control, 6.86 ± 1.57; YG, 5.13 ± 0.83; BP, 4.50 ± 0.55) and ConA-stimulated splenocyte IL-4 secretion (Negative control, 1168.43 ± 553.34 pg/mL; YG, 589.84 ± 233.54 pg/mL; BP, 472.28 ± 186.44 pg/mL). These findings suggest that practical formulation conditions may shape selected preclinical immunological and histopathological responses to L. paracasei Yb. Further studies incorporating CFU-matched dosing, probiotic-free yogurt controls, and mechanistic validation are required before clinical relevance in asthma can be inferred.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Uni-President Enterprises Corporation, Tainan 710401, Taiwan.
- Agricultural Input and Product Valorization Research Center, Agriculture Technology Research Institute, Miaoli 350401, Taiwan.
- Department of Animal Science, National Chung Hsing University, Taichung City 40227, Taiwan.
- The iEGG and Animal Biotechnology Research Center, National Chung Hsing University, Taichung City 40227, Taiwan.
ORCID-Profile: Yu-Yi Chen, Yen-Po Chen
Zitieren
APA
Ho, Y. F., Lee, T. C., Liu, K. W., Zhang, F. Y., Yang, C. Y., Asan, M. A., Chen, Y. Y., Chen, Y. P., & Chen, T. Y. (2026). Practical Formulation-Associated Immunomodulatory Responses of Lacticaseibacillus paracasei Yb in an Ovalbumin-Induced Allergic Airway Inflammation Mouse Model. Microorganisms, 14(7), 1389. https://doi.org/10.3390/microorganisms14071389
Vancouver
Ho YF, Lee TC, Liu KW, Zhang FY, Yang CY, Asan MA, et al. Practical Formulation-Associated Immunomodulatory Responses of Lacticaseibacillus paracasei Yb in an Ovalbumin-Induced Allergic Airway Inflammation Mouse Model. Microorganisms. 2026;14(7):1389. doi:10.3390/microorganisms14071389
BibTeX
@article{Ho2026,
author = {Ho, Yi-Fang and Lee, Tsung-Cheng and Liu, Kai-Wei and Zhang, Fang-Yu and Yang, Chi-Yu and Asan, Muhammet Ali and Chen, Yu-Yi and Chen, Yen-Po and Chen, Tzu-Ying},
title = {Practical Formulation-Associated Immunomodulatory Responses of Lacticaseibacillus paracasei Yb in an Ovalbumin-Induced Allergic Airway Inflammation Mouse Model},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {7},
pages = {1389},
doi = {10.3390/microorganisms14071389}
}
EUVIMED